Heparin-binding EGF-like growth factor

From Food & Medicine Encyclopedia

Heparin-binding EGF-like growth factor (HB-EGF) is a protein that in humans is encoded by the HBEGF gene. It is a member of the EGF family of proteins, which play a role in cell growth, proliferation, and differentiation. HB-EGF is unique among the EGF family due to its ability to bind to heparin.

Function[edit]

HB-EGF is synthesized as a membrane-anchored glycoprotein and is then cleaved to produce a soluble form. It stimulates the proliferation of smooth muscle cells, fibroblasts, and keratinocytes, and is involved in wound healing, cardiac hypertrophy, and heart development. It also plays a role in cancer progression.

Clinical significance[edit]

HB-EGF is overexpressed in several types of cancers, including breast cancer, ovarian cancer, and lung cancer. It is also implicated in the progression of atherosclerosis. In addition, it has been identified as a potential therapeutic target for the treatment of diabetic nephropathy.

See also[edit]

References[edit]

<references />

External links[edit]

Stub icon

This protein-related article is a stub. You can help WikiMD by expanding the page.

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Heparin-binding_EGF-like_growth_factor&oldid=5325737"